This test is most useful if any of these apply to you.
FDCA (furan-2,5-dicarboxylic acid) is one of the more obscure markers on the menu of urinary organic acid testing. It does not have decades of outcome data behind it, and there is no widely accepted clinical threshold that triggers a specific diagnosis. If you have ordered this test, you are almost certainly using it as part of a broader exploratory panel that maps the chemical fingerprints your body is leaving in your urine.
That is the right way to think about it. This is a research-tier marker, useful for pattern recognition across a panel of metabolites, not a standalone diagnostic. Its value is in giving you another data point to track over time, and in pairing it with other organic acids to build a picture of metabolic activity that standard blood and stool tests do not capture.
FDCA is a small carbon-ring compound with two acid groups attached. It is best understood as a downstream product of how your body handles 5-hydroxymethylfurfural (5-HMF), a furan compound formed during the heating of sugar-containing foods such as coffee, bread, dried fruit, honey, and caramel. A controlled human study giving people oral 5-HMF found that FDCA and a related glycine conjugate were the main urinary metabolites, with up to about 90 percent of the dose recovered in urine within 48 hours. In other words, the human pathway from dietary 5-HMF to urinary FDCA has been characterized, even if the relative contributions of different food sources and individual differences in metabolism are not yet fully quantified.
Some organic acid panels historically group FDCA under markers said to reflect gut microbial activity, but the published human evidence points more strongly toward dietary 5-HMF metabolized by the liver as the primary source. Microbes can convert HMF to FDCA in industrial and environmental settings, but their contribution to the FDCA you excrete in urine appears to be limited.
Outside the body, you may have seen the name FDCA in industrial chemistry. It is studied as a building block for bio-based plastics. That work is unrelated to what your urine test measures, but it explains why search results on the molecule often pull up plastics research instead of human health research.
FDCA is one member of a broader family of furan-based molecules that humans encounter and metabolize. Research on related furan compounds has found that everyday exposures meaningfully shift the levels of furan metabolites in urine, even though those studies measured different molecules than the one this test reports.
In an observational study of tobacco, e-cigarette, and cannabis users, urinary furan mercapturic acid metabolites (a related but different measurement) were elevated compared to non-users. A separate biomarker study using urinary GSH-BDA (also a related but different furan metabolite) estimated human exposure to furan in food, and identified tobacco smoke as a significant source and confounder. Neither study measured FDCA directly, so these findings provide context about the furan family rather than direct evidence about this specific test.
Urinary metabolites in general show large day-to-day variation within the same person. Studies of non-persistent organic chemicals in urine consistently find that a single spot urine sample can misclassify a person's true average level, and that pooling multiple samples or repeating the test reduces that error. One investigation of volatile organic compound metabolites in urine reported significant within-individual variability across the day, leading the authors to conclude that single measurements may produce misleading exposure estimates.
This pattern almost certainly applies to FDCA as well, even though it has not been formally studied. Treat your number as one data point in a series. A baseline reading is useful, a repeat in three to six months is more useful, and a third reading a year later starts to show whether you have a consistent personal pattern or whether your first result was noise.
Because FDCA does not have a published clinical cutoff, your own baseline becomes the most important number. The point of repeat testing is not to chase a target. It is to see whether your level is stable, climbing, or falling, and to correlate any movement with what else changed in your life. Diet shifts (especially intake of coffee, bread, dried fruit, and other heat-processed foods rich in 5-HMF), changes in exposure to tobacco smoke or other furan sources, and changes in liver function could all plausibly affect a result like this.
A reasonable cadence for someone using this as part of an organic acid panel: a baseline now, a follow-up at three to six months if you are making targeted changes, and an annual check thereafter to maintain a personal trend line. Always interpret FDCA alongside the other markers on the same panel rather than in isolation.
Several factors can distort a single urine measurement of any organic acid marker. The most important to be aware of:
If your FDCA reading is unusually high or low compared to your previous results, or sits at an extreme on the lab's reference distribution, the first step is to repeat the test rather than act on it. Use the same collection time of day, similar hydration, and a similar dietary window as the original sample.
If the second test confirms the pattern, look at the rest of your organic acid panel. FDCA is most informative when read alongside the other markers in the same report. Patterns across multiple markers are far more meaningful than any single result. If you are working with a clinician who interprets organic acid panels, this is the kind of finding to bring to them rather than to treat empirically on your own.
Furan-2,5-dicarboxylic Acid is best interpreted alongside these tests.
Furan-2,5-dicarboxylic Acid is included in these pre-built panels.